|
Susan Papalia, RN, BSN , has joined Arbios Systems, Inc., as Vice President of Clinical Affairs and brings more than 20 years of clinical research expertise to Arbios Systems, Inc.
Early in her career, Susan held positions as Nurse Manager in hospitals in NY and MA before beginning her research career in cardiovascular medicine while working as a Clinical Research Coordinator/Manager at Tufts/New England Medical Center (Boston, MA). She then went on to design, develop and manage the Peripheral Vascular Program at St. Elizabeth's Hospital of Boston. Susan then focused her energy in the biotech industry and spent 16 productive years at Boston Scientific where she held management positions in US and International Clinical Research. Recently, Susan spent two years working in Europe and, upon her return to the US, assumed responsibility for worldwide post market patient Registries. Prior to leaving Boston Scientific, Susan was the Clinical Program Manager responsible for the strategic development, program management, budget and clinical oversight of the OLYMPIA Registry - the world's largest, global Drug Eluting Stent (DES) Registry - which is designed to capture "real world" clinical outcomes data in ~30,000 patients with coronary artery disease.
In 2006, Susan joined Mitralign, Inc. (Tewksbury, MA) as Director of Clinical Affairs where she was successful in implementing a strategic clinical plan and obtaining international regulatory approvals for Mitralign's feasibility study of a novel percutaneous mitral valve repair system. She served as the liaison between R&D, Quality Affairs, CROs and all outside physician consultants, including medical adjudicators and Core Lab physicians.
At Arbios Systems, Inc., Susan will be instrumental in leading the execution of the IDE pivotal trial of the SEPET Liver Assist Device - a multicenter, randomized, controlled study for the treatment of patients with acute exacerbation of chronic liver disease and severe hepatic encephalopathy. | 